| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $136.0M | — | -2.4% |
| R&D Expense | $187.0M | — | +12.8% |
| SG&A Expense | $88.0M | — | +0.2% |
| Operating Income | -$169.0M | — | -18.2% |
| Pre-tax Income | -$184.0M | — | -22.9% |
| Income Tax | $1.0M | — | -23.7% |
| Net Income | -$185.0M | — | -22.5% |
| EPS (Basic) | -$1.84 | — | -17.2% |
| EPS (Diluted) | -$1.84 | — | -17.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $175.0M | -58.4% | +37.7% |
| Accounts Receivable | $121.0M | -23.4% | +22.4% |
| Inventory | $55.0M | +5.8% | +19.5% |
| Current Assets | $657.0M | -30.9% | -6.0% |
| Total Assets | $1.30B | -15.4% | -1.2% |
| Current Liabilities | $325.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$197.0M | — | -18.3% |
| Capital Expenditures | $1.0M | — | -24.5% |
| Investing Cash Flow | -$49.0M | — | -140.9% |
| Free Cash Flow | -$198.0M | — | -18.0% |
| +11.4% |
| Total Liabilities | $1.52B | -5.0% | +31.4% |
| Stockholders' Equity | -$236.0M | -195.0% | -263.6% |